Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.
Level 5 - mechanism / opinion, no new human data
Clinical practice guideline and expert panel recommendation statement
PubMed 29896632 · doi:10.1001/jama.2018.6848
What was done
The US Preventive Services Task Force (USPSTF) reviewed evidence to update its 2012 recommendation on screening asymptomatic adults with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events, compared to traditional risk assessment tools (such as the Framingham Risk Score or Pooled Cohort Equations).
What was found
The abstract reports no numerical outcome metrics. For asymptomatic adults at low risk of CVD (<10% 10-year risk), ECG screening is very unlikely to reclassify risk or improve health outcomes and carries potential harms from downstream invasive testing, yielding a "D" recommendation against screening. For asymptomatic adults at intermediate or high risk, evidence is insufficient to evaluate the balance of benefits and harms, resulting in an "I" statement.
Why it matters
This guideline clarifies that routine screening ECGs in asymptomatic low-risk adults provide no clinical benefit and risk downstream harms, discouraging unnecessary testing in primary care.
Limits
The abstract reports no numerical data, study counts, or effect estimates. Recommendations are strictly limited to asymptomatic adults and do not apply to diagnostic evaluation of symptomatic patients.
Cited by
- supports Stress tests do not predict heart attacks.